Get started
Work

Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901

Year: 2008
Type: article
Study design: Clinical Trial
DOI: 10.1097/jto.0b013e318161225e
Authors: Stephen L. Graziano, James E. Herndon, Mark A. Socinski, Xiaofei Wang, Dorothy Watson, Everett Vokes, Mark R. Green
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
Funders: Memorial Sloan-Kettering Cancer Center, Syracuse University, University of Missouri, University of Minnesota, University of North Carolina at Chapel Hill, State University of New York Upstate Medical University, National Cancer Institute
Awards: G10814802, G1109514914, WUMC Cancer and Leukemia Group B, G1486637521, G1689128559, Cancer and Leukemia Group B, Illinois Oncology Research Association Community Clinical Oncology Program, G192656225, G211333722, G220937036, G2261465654, G2647518335, Cancer and Leukemia Group B Statistical Center, Southeast Cancer Control Consortium, Inc, Cancer and Leukemia Group B, G3710026009, G3790305154, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B, Delaware/Christiana Care Community Clinical Oncology Program, Cancer and Leukemia Group B, Heartland Cancer Research CCOP, CANCER AND LEUKEMIA GROUP B--MINNESOTA ONCOLOGY GROUP, Cancer and Leukemia Group B, G877081928, G877907214, G973482110, G979369470
OpenAlex ID: W2012368207
FWCI: 0.88
Cites: 26
Cited by: 20
Related to: 10